{"data":[{"accessionNo":"0001950047-26-006832","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"JEFF KNIGHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":47420,"aggregateMarketValue":1834205.6,"unitsOutstanding":105440208,"approxSaleDate":"2026-07-02","exchange":"NASDAQ","filedAt":"2026-07-02"},{"accessionNo":"0001950047-26-006823","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"ROGERIO VIVALDI COELHO","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6000,"aggregateMarketValue":232080,"unitsOutstanding":105440208,"approxSaleDate":"2026-07-02","exchange":"NASDAQ","filedAt":"2026-07-02"},{"accessionNo":"0001950047-26-006257","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"STEPHANIE OKEY","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6900,"aggregateMarketValue":241500,"unitsOutstanding":105440208,"approxSaleDate":"2026-06-17","exchange":"NASDAQ","filedAt":"2026-06-17"},{"accessionNo":"0001950047-26-003982","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"JEFF KNIGHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":9485,"aggregateMarketValue":370104.7,"unitsOutstanding":104705330,"approxSaleDate":"2026-05-04","exchange":"NASDAQ","filedAt":"2026-05-04"},{"accessionNo":"0001950047-26-003450","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"JEFF KNIGHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":20900,"aggregateMarketValue":807994,"unitsOutstanding":104705330,"approxSaleDate":"2026-04-14","exchange":"NASDAQ","filedAt":"2026-04-14"},{"accessionNo":"0001950047-26-003400","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"JEFF KNIGHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":4434,"aggregateMarketValue":174876.96,"unitsOutstanding":104705330,"approxSaleDate":"2026-04-13","exchange":"NASDAQ","filedAt":"2026-04-13"},{"accessionNo":"0001950047-26-003337","issuerCik":"0001658247","issuerName":"CRINETICS PHARMACEUTICALS INC","ticker":"CRNX","personName":"JEFF KNIGHT","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":85163,"aggregateMarketValue":3271110.83,"unitsOutstanding":104705330,"approxSaleDate":"2026-04-08","exchange":"NASDAQ","filedAt":"2026-04-08"},{"accessionNo":"0001950047-26-002789","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"DANA PIZZUTI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":24756,"aggregateMarketValue":938004.84,"unitsOutstanding":104705330,"approxSaleDate":"2026-03-18","exchange":"NASDAQ","filedAt":"2026-03-18"},{"accessionNo":"0001628280-26-017948","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals Inc","ticker":"CRNX","personName":"Jeff Knight","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":25113,"aggregateMarketValue":941486,"unitsOutstanding":104705300,"approxSaleDate":"2026-03-16","exchange":"Nasdaq","filedAt":"2026-03-16"},{"accessionNo":"0001628280-26-017946","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"Richard Scott Struthers","relationship":"Director, Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":45013,"aggregateMarketValue":1687537,"unitsOutstanding":104705300,"approxSaleDate":"2026-03-16","exchange":"Nasdaq","filedAt":"2026-03-16"},{"accessionNo":"0001628280-26-017947","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals Inc.","ticker":"CRNX","personName":"Stephen Betz","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":26525,"aggregateMarketValue":994422,"unitsOutstanding":104705300,"approxSaleDate":"2026-03-16","exchange":"Nasdaq","filedAt":"2026-03-16"},{"accessionNo":"0001950047-26-002543","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"ROGERIO VIVALDI COELHO","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":184900,"unitsOutstanding":104705330,"approxSaleDate":"2026-03-12","exchange":"NASDAQ","filedAt":"2026-03-12"},{"accessionNo":"0001950047-26-002102","issuerCik":"0001658247","issuerName":"CRINETICS PHARMACEUTICALS INC","ticker":"CRNX","personName":"STEPHANIE S OKEY","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":3000,"aggregateMarketValue":122040,"unitsOutstanding":104705330,"approxSaleDate":"2026-03-03","exchange":"NASDAQ","filedAt":"2026-03-03"},{"accessionNo":"0001628280-26-013047","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals Inc","ticker":"CRNX","personName":"Tobin Schilke","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":6800,"aggregateMarketValue":280000,"unitsOutstanding":95575485,"approxSaleDate":"2026-03-02","exchange":"Nasdaq","filedAt":"2026-03-02"},{"accessionNo":"0001950047-26-000824","issuerCik":"0001658247","issuerName":"CRINETICS PHARMACEUTICALS INC","ticker":"CRNX","personName":"DANA PIZZUTI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":10000,"aggregateMarketValue":499400,"unitsOutstanding":94891840,"approxSaleDate":"2026-02-02","exchange":"NASDAQ","filedAt":"2026-02-02"},{"accessionNo":"0001950047-26-000146","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"ISABEL KALOFONOS","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":2500,"aggregateMarketValue":116825,"unitsOutstanding":94891840,"approxSaleDate":"2026-01-05","exchange":"NASDAQ","filedAt":"2026-01-05"},{"accessionNo":"0001950047-26-000066","issuerCik":"0001658247","issuerName":"CRINETICS PHARMACEUTICALS INC","ticker":"CRNX","personName":"DANA PIZZUTI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":232750,"unitsOutstanding":94891840,"approxSaleDate":"2026-01-02","exchange":"NASDAQ","filedAt":"2026-01-02"},{"accessionNo":"0001950047-25-009572","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"DANA PIZZUTI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":227800,"unitsOutstanding":94891840,"approxSaleDate":"2025-12-01","exchange":"NASDAQ","filedAt":"2025-12-01"},{"accessionNo":"0001950047-25-008396","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"DANA PIZZUTI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":217500,"unitsOutstanding":94175994,"approxSaleDate":"2025-11-03","exchange":"NASDAQ","filedAt":"2025-11-03"},{"accessionNo":"0001950047-25-007645","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"DANA PIZZUTI","relationship":"Officer","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":5000,"aggregateMarketValue":208250,"unitsOutstanding":94175994,"approxSaleDate":"2025-10-01","exchange":"NASDAQ","filedAt":"2025-10-01"},{"accessionNo":"0001969223-25-000799","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"Struthers Richard Scott","relationship":"Officer, Director","securityClass":"Common","broker":"UBS Financial Services Inc.","unitsToSell":4000,"aggregateMarketValue":180000,"unitsOutstanding":94175994,"approxSaleDate":"2025-09-26","exchange":"NASDAQ","filedAt":"2025-09-26"},{"accessionNo":"0001950047-25-007529","issuerCik":"0001658247","issuerName":"Crinetics Pharmaceuticals, Inc.","ticker":"CRNX","personName":"MATTHEW K FUST","relationship":"Director","securityClass":"Common","broker":"Morgan Stanley Smith Barney LLC Executive Financial Services","unitsToSell":16000,"aggregateMarketValue":574240,"unitsOutstanding":94175994,"approxSaleDate":"2025-09-26","exchange":"NASDAQ","filedAt":"2025-09-26"}],"updatedAt":"2026-10-13T09:53:05.215Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","meta":{"source":"SEC","sourceAttribution":"Form 144 data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}